Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|July 10, 2020
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrationsR Palich, M Wirden, G Peytavin, et al.
HIV Clinical Trials|February 3, 2006
Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS studyR Landman, D Descamps, G Peytavin, et al.
AIDS Research and Human Retroviruses|May 12, 2010
Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in SenegalRoland Landman, M B Diallo, N F Ngom Gueye, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 13, 2009
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugsL Tricot, E Teicher, G Peytavin, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2008
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavirB Masquelier, K L Assoumou, D Descamps, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2008
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patientsD Rey, B Hoen, P Chavanet, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2025
Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015-22: experience from an HIV clinic in Paris, FranceL Sagaon-Teyssier, A Eremin, M A Valantin, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2018
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencingT Nguyen, D B Fofana, M P Lê, et al.
Pageof 8